Drug
Who makes gallium ga-68 gozetotide?
3 companies list gallium ga-68 gozetotide as a human prescription drug. Forms: injection, solution. Routes: intravenous.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing gallium ga-68 gozetotide
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Ionetix CorporationUnited States | injection, solution | ANDAANDA219189 | 1 | 9 |
| UCSF Radiopharmaceutical FacilityUnited States | injection, solution | NDANDA212643 | 1 | 1 |
| UCLA Biomedical Cyclotron | injection, solution | NDANDA212642 | 1 | 0 |
Orange Book patents
3 unexpired patents list gallium ga-68 gozetotide as the active ingredient, expiring between Aug 2028 and Mar 2036. Application holders: NOVARTIS PHARMACEUTICALS CORP, TELIX INNOVATIONS SA, TELIX PHARMACEUTICALS US INC.
Enquiry
Common questions
- Who makes gallium ga-68 gozetotide?
- 3 companies list gallium ga-68 gozetotide as a human prescription drug in the openFDA NDC Directory, led by Ionetix Corporation, UCSF Radiopharmaceutical Facility, UCLA Biomedical Cyclotron. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic gallium ga-68 gozetotide?
- 1 company lists gallium ga-68 gozetotide under an abbreviated new drug application (ANDA), the application type used for generics, and 2 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.